"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Roxane Laboratories Inc.","Hikma Pharmaceuticals","$280,000,000","$0","$280,000,000","2010","20101207","government-contracting-related offenses","False Claims Act and related","","Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases",""
"Boehringer Ingelheim Roxane, Inc.","Hikma Pharmaceuticals","$1,800,000","$0","$1,800,000","2008","20080922","government-contracting-related offenses","False Claims Act and related","","Boehringer Ingelheim Roxane, Inc. agreed to pay $1.8 million in settlement of alleged improper reporting of the average wholesale price of its drugs, causing Medicaid to pay inflated amounts.","state","agency action","Massachusetts Attorney General","civil","","","","","","Massachusetts","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20090115030429/http://www.mass.gov/?pageID=cagopressrelease&L=1&L0=Home&sid=Cago&b=pressrelease&f=2008_09_22_boehringer_ingelheim_roxane&csid=Cago",""
"Boehringer Ingelheim Roxane, Inc. et al.","Hikma Pharmaceuticals","$357,000","$0","$357,000","2009","20091113","government-contracting-related offenses","False Claims Act and related","","A group of seven pharmaceutical companies agreed to pay Iowa a total of $4.3 million to settle a lawsuit alleging false reporting of average wholesale prices, thus increasing costs for the state's Medicaid program. The announcement did not specify how much each company would pay. Here we assume the total was divided equally among them.","state","agency action","Iowa Attorney General","civil","","","","","","Iowa","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20110114073554/http://www.state.ia.us/government/ag/latest_news/releases/nov_2009/Little_Group_AWP_settlement.html","Abbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement"
"Roxane Laboratories Inc.","Hikma Pharmaceuticals","$2,400,000","$0","$2,400,000","2009","20090528","government-contracting-related offenses","False Claims Act and related","","Misleading reporting on wholesale drug prices, inflating costs for Medicaid.","state","agency action","Ohio Attorney General","civil","","","","","","Ohio","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20101227185039/http://www.ohioattorneygeneral.gov/Briefing-Room/News-Releases/May-2009/Attorney-General-Cordray-Announces-$8-44-Million-S",""
"Roxane Laboratories, Inc.","Hikma Pharmaceuticals","$8,500,000","$0","$8,500,000","2009","20091209","government-contracting-related offenses","False Claims Act and related","","","state","agency action","Florida Attorney General","civil","","","","","","Florida","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","Florida Recovers $8.5 Million from Pharmaceutical Company in Medicaid Fraud Settlement, Targeted News Service, December 9, 2009 (via Nexis).",""
"Roxane Laboratories, Inc.","Hikma Pharmaceuticals","$357,000","$0","$357,000","2009","20091113","government-contracting-related offenses","False Claims Act and related","","A group of seven pharmaceutical companies agreed to pay Iowa a total of $4.3 million to settle a lawsuit alleging false reporting of average wholesale prices, thus increasing costs for the state's Medicaid program. The announcement did not specify how much each company would pay. Here we assume the total was divided equally among them.","state","agency action","Iowa Attorney General","civil","","","","","","Iowa","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20110114073554/http://www.state.ia.us/government/ag/latest_news/releases/nov_2009/Little_Group_AWP_settlement.html","Abbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement"
"Roxane, Inc.","Hikma Pharmaceuticals","$3,100,000","$0","$3,100,000","2010","20100324","government-contracting-related offenses","False Claims Act and related","","Roxane, Inc., later known as Boehringer Ingelheim Roxane, Inc., agreed to pay $3.1 million in settlement of alleged improper reporting of the average wholesale price of its drugs, causing Medicaid to pay inflated amounts.","state","agency action","Missouri Attorney General","civil","","","","","","Missouri","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20100612204010/http://ago.mo.gov/newsreleases/2010/Koster_says_pharmaceutical_company_to_pay_3_1_million_in_Medicaid_fraud_settlement/",""
"Roxanne Laboratories and Boehringer Ingelheim","Hikma Pharmaceuticals","$9,500,000","$0","$9,500,000","2008","20081223","government-contracting-related offenses","False Claims Act and related","","Medicaid average wholesale price litigation.","state","agency action","Alabama Attorney General","civil","","","","","","Alabama","","","","","","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","Attorney General Announces $28 Million in New Settlements with Drug Companies, press release transmitted by US States News, December 23, 2008 and Terms of Medicaid Drug Suit Settlements Announced, Associated Press, December 23, 2008 (both via Nexis).",""
"HIKMA PHARMACEUTICALS","Hikma Pharmaceuticals","$40,959","$0","$40,959","2020","20201005","safety-related offenses","workplace safety or health violation","","","federal","agency action","Occupational Safety & Health Administration","civil","","","","","","New Jersey","CHERRY HILL","2 ESTERBROOK LANE","08003","325412","325412: Pharmaceutical Preparation Manufacturing","United Kingdom","","publicly traded","","pharmaceuticals","pharmaceuticals","Extracted from a download of OSHA's Enforcment Data downloaded on 3/02/2022, available at https://enforcedata.dol.gov/views/data_catalogs.php",""
